Marshall Wace’s Rein Therapeutics RNTX Stock Holding History

Marshall Wace’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$127K	Buy	+158,435	New	+$130K	﹤0.01%	2903

Other funds holding RNTX

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return

Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return

Senvest Management New York $3.45B AUM 44.97% 1-Year Est. Return

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $798M AUM 22.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return

Marshall Wace's RNTX Position: Q3 2026 in Review

Marshall Wace opened a new position in Rein Therapeutics (RNTX) in Q3 2026: 158,435 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #2903 among its holdings.

47 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

Marshall Wace held 158,435 shares of Rein Therapeutics worth $127K as of Q3 2026.
Rein Therapeutics was a new Marshall Wace position in Q3 2026.
Rein Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q3 2026, its #2903 holding.
47 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.